Drug Report Submissions by Marketing Firms: DTAB directs to constitute sub-committee to amend NDCT Rules Farhat Nasim20 Oct 2024 1:00 PM ISTNew Delhi: The Drugs Technical Advisory Board (DTAB) has recommended forming a sub-committee to look into the proposed amendments to the New Drugs and...
DCGI to bring non-invasive medical devices like thermometers, stethoscopes under quality control Farhat Nasim19 Oct 2024 4:39 PM ISTNew Delhi: The Drugs Technical Advisory Board (DTAB) has approved a proposal to amend Rules 19H and 19J of Chapter IIIB of the Medical Devices Rules,...
DoP orders NPPA to re-evaluate ceiling price of vitamin product Thiamin 100 mg Farhat Nasim18 Oct 2024 5:53 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP) has instructed the National Pharmaceutical Pricing Authority (NPPA) to re-examine and recalculate...
NPPA fixes retail prices of 20 formulations, Details Dr. Divya Colin17 Oct 2024 4:27 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) , Ministry of Chemicals and Fertilizers, Government of India...
Abbott's review plea challenging NPPA ceiling price fixation of 18 formulations rejected by DoP Farhat Nasim16 Oct 2024 4:59 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP) has dismissed two review applications filed by Abbott Healthcare Private Limited (AHPL) challenging...
NPPA Approves 50 percent Price Increase of 8 essential drugs, details MD Bureau15 Oct 2024 1:38 PM ISTDelhi: The National Pharmaceutical Pricing Authority (NPPA) has announced a 50% increase in the ceiling prices of eleven scheduled formulations...
DCGI bans this popular anti-cold FDC for children under 4 Farhat Nasim14 Oct 2024 4:25 PM ISTNew Delhi: The Drug Controller General of India (DCGI) has banned use of popular anti-cold cocktail medicine combination for children under four years...
Rs 9.81 crore expenditure on Conference fees, accommodation to doctors, Business Promotion done by Sun Pharma disallowed:Â ITÂ Tribunal Farhat Nasim13 Oct 2024 12:15 PM ISTAhmedabad: The Income Tax Appellate Tribunal (ITAT) in Ahmedabad has upheld the disallowance of more than Rs 9.81 crore incurred by Sun Pharma...
Anti cancer medicines now under Schedule H2 of Drugs Rules, Here is what it means Farhat Nasim12 Oct 2024 12:30 PM ISTNew Delhi: In order to track the movement of anti-cancer drugs and prevent counterfeiting, the Drug Technical Advisory Board (DTAB) has agreed to...
Soon, harsher penalties for submitting false data for drug approval Farhat Nasim11 Oct 2024 3:04 PM ISTNew Delhi: Soon, there will be a stringent action against pharma companies who submit forged or false data for drug approval for sales in the...
Pharma-sponsored Indian CMEs allowed, but Govt sets speaker-to-participant ratios for such events Farhat Nasim10 Oct 2024 4:08 PM ISTNew Delhi: Noting that pharma-sponsored Continuing Medical Education (CME)/ Continuing Professional Development (CPD) programs that are being...
Submit efficacy data of Indian population: CDSCO Panel Tells Eli Lilly for approval of additional indications of Ixekizumab Dr. Divya Colin9 Oct 2024 6:00 PM ISTNew Delhi: Citing that there is no efficacy data in the Indian population, the Subject Expert Committee (SEC) functional under the Central Drug...
